DURHAM, N.C., March 4, 2025 /PRNewswire/ -- Levee Medical is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted approval to initiate the ARID II (A Pivotal Study of VoRo ...

University Hospital Sharjah, with the support of an Irish medical team, successfully performed a rare surgery on a 50-year old patient who was suffering from post-prostatectomy incontinence. Sharjah - ...

PORTOS gene signature as a predictor of risk of adverse events after dose-escalated vs. lower-dose prostate radiation therapy in NRG/RTOG 0126. Five-year changes in urinary function and prostate ...